ESC 365 - Time in therapeutic range and risk of thromboembolism and bleeding in patients with mechanical heart valve prosthesis

ESC Premium Access

Time in therapeutic range and risk of thromboembolism and bleeding in patients with mechanical heart valve prosthesis

Session: Poster Session 5 - Thrombosis and antithrombotic treatment in valvular heart disease

Topic: Surgery

Speaker: Doctor E. Havers-Borgersen (Copenhagen, DK)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Eva Havers-Borgersen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

1 follower

9 more presentations in this session

Dabigatran improves antibiotic efficacy in experimental Staphylococcus aureus endocarditis

Speaker: Doctor C. Lerche (Copenhagen, DK)

High-molecular-weight von Willebrand factor multimer ratio for the differentiation between true-severe and pseudo-severe low-flow, low-gradient aortic stenosis

Speaker: Doctor J. Kellermair (Linz, AT)

Impact of on-clopidogrel platelet reactivity on incidence of hypo-attenuated leaflet thickening after transcatheter aortic valve implantation

Speaker: Doctor T. Nuehrenberg (Bad Krozingen, DE)

Is long-term oral anticoagulation plus an antiplatelet drug better than anticoagulants alone after concomitant heart valve replacement and coronary artery bypass surgery?

Speaker: Doctor I. Cho (Seoul, KR)

Evaluation of D-dimer levels in patients with prosthetic valve thrombosis: relationship with thrombus burden and cerebrovascular events

Speaker: Doctor S. Cersit (Istanbul, TR)

Access the full session

Poster Session 5 - Thrombosis and antithrombotic treatment in valvular heart disease

Speakers: Doctor E. Havers-Borgersen, Doctor C. Lerche, Doctor J. Kellermair, Doctor T. Nuehrenberg, Doctor I. Cho...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources